Position in ZYBT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$243
-$1,604 QoQ
Shares Held
261
-83.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 7 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZYBT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $4,148,152,984 across 73 Drug Manufacturers - Specialty & Generic names. ZYBT ranks #69 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
14,145,735 | $1,672,167,321 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
409,288 | $242,699,592 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,426,253 | $223,678,734 | |
| 4 | VTRS |
Viatris Inc
|
16,089,939 | $217,375,067 | |
| 5 | HLN |
Haleon plc
|
19,166,253 | $191,854,187 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
8,889,088 | $184,537,462 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
1,219,196 | $160,616,870 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
6,417,527 | $153,571,413 |
All Filings in ZYBT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $243 | 261 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,847 | 1,607 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $5,263 | 2,009 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $14,542 | 2,436 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $247 | 46 | Shares | Defined | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||